Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04770337Not ApplicableCompleted

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Role: lead

NCT06165445Not ApplicableCompleted

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

Role: collaborator

NCT06334952Not ApplicableRecruiting

Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic

Role: collaborator

NCT05489146Not ApplicableCompleted

t-RNS After Hand Recovery in Chronic Stroke

Role: collaborator

NCT05205915Not ApplicableUnknown

Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD)

Role: lead

NCT02866240Not ApplicableCompleted

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Role: lead

NCT03144102Not ApplicableUnknown

Combining tDCS With VR-based Motor Training in Stroke

Role: collaborator

NCT03943979Phase 2Completed

Pilot Study of an Intervention Involving Cognitive Training and tDCS in Morbidly Obese Subjects

Role: collaborator

All 8 trials loaded